Literature DB >> 32243160

Synthesis and Cytotoxicity Studies of Stilbene Long-Chain Fatty Acid Conjugates.

Thomas Wong1, Silpa Narayanan1, David P Brown2, Zhe-Sheng Chen1.   

Abstract

A series of 16 conjugates of the tubulin polymerization inhibitor combretastatin A4 (CA-4) and other functionally related stilbene with four 18-carbon fatty acids, namely, stearic, oleic, linoleic, and linolenic acids, have been synthesized in good yields. These new derivatives have been evaluated against the KB-3-1 (human epidermoid carcinoma), NCI-H460 (human lung cancer), HEK293 (human embryonic kidney), and MCF-7 (human breast adenocarcinoma) cell lines for antiproliferative activity, with the exhibited cytotoxic activities comparable with those of CA-4 and colchicine. Compounds 22 and 23, CA-4 conjugates of linoleic and linolenic acids, respectively, were determined to have exhibited the most active in vitro assays, with compound 23 exhibiting very similar activity to the parent compound against the NCI-H460 cell line. Our studies further delineated the structurally required Z-geometry of the stilbene moiety and that conjugation of the less active E-stilbenes with the most active fatty acid had minimal or no improvement in their respective activities.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32243160     DOI: 10.1021/acs.jnatprod.0c00027

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

1.  The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter.

Authors:  Silpa Narayanan; Nehaben A Gujarati; Jing-Quan Wang; Zhuo-Xun Wu; Jagadish Koya; Qingbin Cui; Vijaya L Korlipara; Charles R Ashby; Zhe-Sheng Chen
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

Review 2.  Structural derivatization strategies of natural phenols by semi-synthesis and total-synthesis.

Authors:  Ding Lin; Senze Jiang; Ailian Zhang; Tong Wu; Yongchang Qian; Qingsong Shao
Journal:  Nat Prod Bioprospect       Date:  2022-03-07

3.  The Spleen Tyrosine Kinase Inhibitor, Entospletinib (GS-9973) Restores Chemosensitivity in Lung Cancer Cells by Modulating ABCG2-mediated Multidrug Resistance.

Authors:  Silpa Narayanan; Zhuo-Xun Wu; Jing-Quan Wang; Hansu Ma; Nikita Acharekar; Jagadish Koya; Sabesan Yoganathan; Shuo Fang; Zhe-Sheng Chen; Yihang Pan
Journal:  Int J Biol Sci       Date:  2021-06-22       Impact factor: 6.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.